Life Sciences & Healthcare

Switzerland

Our Life Sciences & Healthcare team consists of specialised attorneys who will advise and represent you in all legal matters competently and tailored to the special needs of your company. 

With more than 300 lawyers specialising in the Life Sciences & Healthcare sector worldwide and the support of the Life Sciences Asia Pacific Network (LAN), we at CMS are very familiar with the economic, commercial and legal needs of our clients in those industries.

Reputation

We have been working successfully for many years with leading companies in the Life Sciences sector in the fields of pharmaceuticals, medical devices, biotechnology, chemistry, foodstuffs and cosmetics. These include the world’s most important pharmaceutical companies and the world’s leading medical device companies. In the Healthcare sector, we advise and represent all relevant medical service providers (hospitals, HMOs, nursing homes, laboratories, physicians, pharmacists, etc.) and their associations.

Comprehensive advice and representation

We regularly advise our Life Sciences clients on their day-to-day business, for example in:

  • Research and development (particularly in clinical trials)
  • Patent enforcement
  • Regulatory authorisations
  • Advertising and distribution issues
  • Pricing strategies and reimbursements under social security law
  • Compliance
  • Data protection

We support our Healthcare clients in particular in the areas of:

  • Social security regulatory authorisations
  • Professional law
  • Data protection
  • Tariff negotiations and tariff settings
  • Planning (hospital planning, planning of highly-specialised medicine)
  • Liability issues and compliance

Whether you require professional support in the area of contracts, strategic agreements or in competition and antitrust law, or an expert opinion, are planning a corporate transaction or seek to engage in legal proceedings or are affected by legal, administrative or criminal proceedings, we would be delighted to assist you.

Industry knowledge

Many of our experts have worked in Life Sciences & Healthcare companies prior to joining CMS, gaining extensive knowledge in pharmaceuticals, medical devices, biotechnology, chemistry, foodstuffs, cosmetics and medical services. Through our active membership in the most important industry associations and our participation in the legislative process, we contribute to shaping the legal and regulatory framework for the Life Sciences & Healthcare sector.


Find out more in our Life Sciences & Healthcare brochure

Read more Read less

CMS offers advice on regulatory and pricing issues, commercial cooperation agreements, product advertising and compliance programs. The team assisted Synlab International with its compliance program roll-out of in Switzerland and continues to represent Bayer in Swiss administrative proceedings concerning a pricing matter.

Legal500, Switzerland, 2018: Healthcare and Life Sciences
Life Sci­ences & Health­care Prac­tice Group Switzer­land

Feed

Show only
Marite Aragaki
Dec 2018
CMS Life Sci­ences & Health­care Sec­tor Group: An over­view...
24/08/2018
Gov­ern­ment Is­sues Brexit Tech­nic­al No­tice for Life Sci­ences
On 23 Au­gust 2018, the UK Gov­ern­ment (the "Gov­ern­ment") is­sued the first wave of its tech­nic­al pa­pers de­signed to provide guid­ance to com­pan­ies to help pre­pare for a "No Deal" Brexit. In this scen­ario, there will be no "trans­ition peri­od" but rather the UK.
Sep 2018
Di­git­isa­tion in health­care: From uto­pia to real­ity...
#law­volu­tion
25/01/2018
European Com­mis­sion as­sesses ad­equacy of Gen­er­al Food Law in food...
In an eval­u­ation of the EU le­gis­lat­ive frame­work for the 2002 Gen­er­al Food Law Reg­u­la­tion (GFLR), the European Com­mis­sion has found that this frame­work ap­pears to ad­dress most cur­rent trends, such as growth, com­pet­it­ive­ness and in­creased glob­al­isa­tion, but.
Dr Patrick Sommer, H.E.E.
21/08/2018
Your in­tro­duc­tion to CMS Switzer­land
13/12/2017
Um­strittene Planung­sentscheide im Bereich der hoch­spezi­al­is­ier­ten...
Die Planung der hoch­spezi­al­is­ier­ten Med­iz­in (HSM) wird von al­len Kantonen ge­mein­sam durchge­führt. Die Entscheide des zuständi­gen Beschlus­sor­gans sind oft um­strit­ten. Nicht alle sind aber gleich­er­massen an­fecht­bar.
17/04/2018
Life Sci­ences & Health­care Prac­tice Group Switzer­land
16/01/2018
New part­ner and new coun­sels at CMS
27/11/2017
CMS is part of the new Law journ­al for pharma, bi­otech,...
06.01.2017
CMS von Er­lach Pon­cet Ltd. is ex­pand­ing its leg­al ad­vis­ory...
20/06/2016
CMS An­nu­al Re­view 2015-2016
De­liv­er­ing leg­al ex­pert­ise to trans­form your busi­ness
10/12/2015
CMS Glob­al Lifes­ci­ences For­um 2015 in Frank­furt tackles...